outcomes research

Quiz

Friday Morning Quiz: Week of September 18-24

09/22/2016

JCP Editors

A study published in the New England Journal of Medicine showed that localized prostate cancer is more likely to metastasize if patients receive which of the following treatments? radiation therapy active...

A...

09/22/2016

Journal of Clinical Pathways

Department

Integrating Precision Medicine Into Chronic Lymphocytic Leukemia Pathways

09/21/2016

JCP Editors

“It is time to rethink how we treat chronic lymphocytic leukemia (CLL),” said Chadi Nabhan, MD, MBA, FACP, Cardinal Health Specialty Solutions (Chicago, IL) during a session at the Clinical Pathways Congress, where...

“It is...

09/21/2016

Journal of Clinical Pathways

Research in Review

No Difference in 5-Year Survival With Lung Cancer Staging Strategies

09/21/2016

JCP Editors

New data from a post-hoc analysis of the Assessment of Surgical Staging vs Endosonographic Ultrasound in Lung Cancer (ASTER) trial found no survival difference at 5 years with endosonography or mediastinoscopy...

New...

09/21/2016

Journal of Clinical Pathways

Research in Review

Prostate Cancer Metastasis More Common Among Patients Receiving Active Surveillance

09/21/2016

JCP Editors

While survival at 10 years is similar, localized prostate cancer may be more likely to metastasize in men receiving active surveillance compared with those who have surgery or radiation therapy, according to results...

While...

09/21/2016

Journal of Clinical Pathways

Department

Critical Considerations in Colorectal Pathway Development

09/19/2016

JCP Editors

In an early session at the Clinical Pathways Congress, Bert H O’Neil, MD, Indian University Simon Cancer Center (Indianapolis, IN) discussed some of the important factors to consider when developing a clinical...

In an...

09/19/2016

Journal of Clinical Pathways

Research in Review

Novel Tumor Analysis Method Identifies Aggressive Prostate Cancer

09/17/2016

JCP Editors

Despite recent advances in understanding prostate cancer heterogeneity, better methods for classification of prostate cancer are still needed. Researchers at Cedars-Sinai have developed a new method to identify which...

...

09/17/2016

Journal of Clinical Pathways

Research in Review

Factors Associated With Early Death Among Elderly Patients With Lymphoma

09/14/2016

JCP Editors

Administrative and cancer registry data, routinely integrated within modern electronic medical records, can help determine which patients with lymphoma are at the highest risk of dying from chemotherapy, according to...

...

09/14/2016

Journal of Clinical Pathways

Research in Review

HAPs Prevent Treatment Resistance in EGFR+ NSCLC

09/12/2016

JCP Editors

Adding a hypoxia-activated prodrug (HAP) to standard care for epidermal growth factor receptor-positive non-small cell lung cancer may help to delay treatment resistance, according to a study published in PLOS...

Adding...

09/12/2016

Journal of Clinical Pathways

Research in Review

Two Biomarkers Predict Treatment Response to Rituximab in RA

09/09/2016

JCP Editors

A 24-week observational study found that a combination of the cellular biomarkers—lymphocyte count (LC) and plasmablast frequency—helps identify patients with rheumatoid arthritis (RA) who will not benefit from...

A...

09/09/2016

Journal of Clinical Pathways

Research in Review

Vinblastine for Low-Grade Glioma Has Few Side Effects and Comparable Survival

09/09/2016

JCP Editors

Vinblastine monotherapy has similar outcomes and a more favorable toxicity profile compared with current therapies when used in patients with treatment naïve pediatric low-grade glioma (PLGG), according to a study...

...

09/09/2016

Journal of Clinical Pathways